tiprankstipranks
Windtree Therapeutics (WINT)
OTHER OTC:WINT
US Market
WINT
Windtree Therapeutics
RESEARCH TOOLSreports
Want to see WINT full AI Analyst Report?

Windtree Therapeutics (WINT) Income Statement

390 Followers

Windtree Therapeutics Income Statement

Last quarter (Q3 2025), Windtree Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Windtree Therapeutics's net income was $-28.09M. See Windtree Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -84.00K$ -82.00K$ -1.06M$ -869.00K$ -638.00K
Operating Expenses
$ 24.93M$ 17.46M$ 20.43M$ 31.39M$ 30.32M
Depreciation and Amortization
$ 84.00K$ 82.00K$ 1.06M$ 869.00K$ 638.00K
EBITDA
$ -1.47M$ -20.16M$ -39.46M$ -76.64M$ -31.80M
Operating Income
$ -25.02M$ -17.54M$ -41.33M$ -77.28M$ -30.32M
Other Income/Expenses
$ 23.23M$ -2.75M$ 758.00K$ -45.36M$ -2.25M
Pretax Income
$ -1.79M$ -20.29M$ -40.58M$ -77.62M$ -32.57M
Net Income
$ -5.49M$ -20.29M$ -39.21M$ -67.64M$ -30.28M
Per Share Metrics
Basic EPS
$ -104.35$ -4.71K$ -56.01K$ -122.92K$ -93.62K
Diluted EPS
$ -104.35$ -4.71K$ -56.01K$ -122.92K$ -93.62K
Weighted Average Shares Outstanding
 52.58K 4.31K 700.00--
Weighted Average Shares Outstanding (Diluted)
 52.58K 4.31K 700.00--
Currency in USD

Windtree Therapeutics Earnings and Revenue History